Biolchim-Cifo agrees to buy 60% of Ilsa S.p.A.
Thanks to its three production facilities, two of which based in Italy (Arzignano and Molfetta) and one in Brazil (Porto Alegre), and to its selected distribution network operating both in the Italian market and abroad, the 2016 turnover of Ilsa S.p.A. amounted to nearly EUR 22 million with an EBITDA of around EUR 3 million.
Through this transaction the group will have 8 manufacturing plants, 8 business branches, and approximately 300 employees operating in 80 countries, with companies able to manufacture all the main raw materials required for the bio-stimulant production.
The 2016 turnover of the Biolchim-Cifo Group was nearly EUR 85 million, with an EBITDA of about EUR 16.5 million; adding Ilsa S.p.A., the gross revenue will become approx. EUR 115 million in 2017.
“We continue our path towards the strengthening of our Group in the markets through the industrial and technological development and the vertical integration that were completed by this transaction,” said Mr. Leonardo Valenti, CEO of the Biolchim-Cifo Group. “We found a great similarity with Ilsa as to the R&D strategic approach that both companies have carried out over the last ten years, so we are sure that our union will speed-up the time-to-market processes as to the new products and the new technologies".
Mr. Paolo Girelli, Chairman of Ilsa Spa, said: “We deeply believe in this project because of the strong complementarity of the two companies that will allow us to accelerate the strengthening process of our already implemented industrial capacity and to extend and complete our range of products, as well as to increase quickly our position in the foreign markets”.
For more information:
BIOLCHIM S.p.A.
Tel: +39 051 6971842
www.biolchim.it